After Bonferroni correction, BRCA1 tumors were most frequently associated with invasive ductal carcinoma, whereas BRCA2 tumors were more frequently associated with ductal carcinoma in situ (p < 0.001). This evidence concerns the gene BRCA2 and invasive ductal breast carcinoma.